We are live on
!
Find out more
PBM
Propel Bio Management Portfolio holdings
AUM
$159M
1-Year Est. Return
60.94%
This Fund
S&P 500
This Quarter
Est. Return
+35.53%
1 Year Est. Return
+60.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$172M
AUM Growth
+$18.2M
(+12%)
Cap. Flow
-$8.9M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
90.77%
Holding
27
New
3
Increased
3
Reduced
3
Closed
6
Top Buys
| 1 |
Zevra Therapeutics
ZVRA
|
+$1.22M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$1.03M |
| 3 |
Ardelyx
ARDX
|
+$864K |
| 4 |
CMPS
Compass Pathways
CMPS
|
+$564K |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$417K |
Top Sells
| 1 |
Fulcrum Therapeutics
FULC
|
+$4.65M |
| 2 |
Abeona Therapeutics
ABEO
|
+$3.26M |
| 3 |
Plains GP Holdings
PAGP
|
+$1.9M |
| 4 |
Kayne Anderson Energy Infrastructure Fund
KYN
|
+$1.52M |
| 5 |
Trevi Therapeutics
TRVI
|
+$775K |
Sector Composition
| 1 | Healthcare | 83.54% |
| 2 | Energy | 13.65% |
| 3 | Technology | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLT
1
DELISTED
Applied Therapeutics
APLT
| $55.8M | 32.38% |
6,567,858
| – | – |
|
|
2
Plains GP Holdings
PAGP
$4.97B
| $23.5M | 13.65% |
1,272,360
-100,000
| -7% | -$1.9M |
|
3
Phathom Pharmaceuticals
PHAT
$881M
| $15.7M | 9.12% |
869,927
| – | – |
|
4
Achieve Life Sciences
ACHV
$650M
| $11.6M | 6.74% |
2,453,092
| – | – |
|
5
TScan Therapeutics
TCRX
$60.3M
| $10.4M | 6.03% |
2,087,139
| – | – |
|
|
AKRO
6
DELISTED
Akero Therapeutics
AKRO
| $9.86M | 5.72% |
343,729
+15,977
| +5% | +$417K |
|
7
Madrigal Pharmaceuticals
MDGL
$12.7B
| $9.13M | 5.3% |
43,032
| – | – |
|
|
RNAM
8
DELISTED
Avidity Biosciences
RNAM
| $8.2M | 4.76% |
178,500
| – | – |
|
|
9
Ardelyx
ARDX
$1.31B
| $7.38M | 4.28% |
1,070,947
+146,364
| +16% | +$864K |
|
10
Telesat
TSAT
$577M
| $4.82M | 2.79% |
365,781
| – | – |
|
|
11
Abeona Therapeutics
ABEO
$415M
| $3.94M | 2.29% |
624,022
-624,022
| -50% | -$3.26M |
|
12
Kymera Therapeutics
KYMR
$9.39B
| $2.67M | 1.55% |
56,359
| – | – |
|
|
13
Syndax Pharmaceuticals
SNDX
$2.08B
| $2.57M | 1.49% |
133,259
+50,000
| +60% | +$1.03M |
|
14
Kura Oncology
KURA
$1.01B
| $2.54M | 1.47% |
130,000
| – | – |
|
|
15
Zevra Therapeutics
ZVRA
$766M
| $1.25M | 0.72% |
+179,874
| New | +$1.22M |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.24M | 0.72% |
146,381
| – | – |
|
|
LONA
17
LeonaBio Inc
LONA
$80.1M
| $666K | 0.39% |
149,279
| – | – |
|
|
CMPS
18
Compass Pathways
CMPS
$1.8B
| $504K | 0.29% |
+80,000
| New | +$564K |
|
19
Verrica Pharmaceuticals
VRCA
$97.2M
| $500K | 0.29% |
34,494
-8,000
| -19% | -$360K |
|
|
HELP
20
Cybin Inc
HELP
$404M
| – | – |
-22,368
| Closed | -$230K |
|
|
21
Fulcrum Therapeutics
FULC
$237M
| – | – |
-750,000
| Closed | -$4.65M |
|
|
22
Kayne Anderson Energy Infrastructure Fund
KYN
$2.39B
| – | – |
-147,033
| Closed | -$1.52M |
|
|
23
Trevi Therapeutics
TRVI
$2.58B
| – | – |
-260,000
| Closed | -$775K |
|
Similar funds
OS
OC
JF
1L
USWIA
AWP
RWM
EWA